paper-with-me

홈 › Papers

Machine Learning Small Molecule Properties in Drug Discovery

2023-08-02 · Nikolai Schapin, Maciej Majewski, Alejandro Varela, Carlos Arroniz, Gianni de Fabritiis

Machine learning (ML) is a promising approach for predicting small molecule properties in drug discovery. Here, we provide a comprehensive overview of various ML methods introduced for this purpose in recent years. We review a wide range of properties, including binding affinities, solubility, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). We discuss existing popular datasets and molecular descriptors and embeddings, such as chemical fingerprints and graph-based neural networks. We highlight also challenges of predicting and optimizing multiple properties during hit-to-lead and lead optimization stages of drug discovery and explore briefly possible multi-objective optimization techniques that can be used to balance diverse properties while optimizing lead candidates. Finally, techniques to provide an understanding of model predictions, especially for critical decision-making in drug discovery are assessed. Overall, this review provides insights into the landscape of ML models for small molecule property predictions in drug discovery. So far, there are multiple diverse approaches, but their performances are often comparable. Neural networks, while more flexible, do not always outperform simpler models. This shows that the availability of high-quality training data remains crucial for training accurate models and there is a need for standardized benchmarks, additional performance metrics, and best practices to enable richer comparisons between the different techniques and models that can shed a better light on the differences between the many techniques.

📄 PDF Abstract BibTeX arXiv:2308.12354

Code (0)

등록된 구현이 없습니다.

Tasks

Decision MakingDrug Discovery

Similar Papers 제목 키워드 기반

Graph-structured Small Molecule Drug Discovery Through Deep Learning: Progress, Challenges, and Opportunities

2025-02-13 · Kun Li, Yida Xiong, Hongzhi Zhang, Xiantao Cai 외

Due to their excellent drug-like and pharmacokinetic properties, small molecule drugs are widely used to treat various diseases, making them a critical component of drug discovery. In recent years, with the rapid develop…

Drug DiscoveryOut-of-Distribution Generalization

Towards Evolutionary-based Automated Machine Learning for Small Molecule Pharmacokinetic Prediction

2024-08-01 · Alex G. C. de Sá, David B. Ascher

Machine learning (ML) is revolutionising drug discovery by expediting the prediction of small molecule properties essential for developing new drugs. These properties -- including absorption, distribution, metabolism and…

AutoMLDrug Discovery

Low Data Drug Discovery with One-shot Learning

2016-11-10 · Han Altae-Tran, Bharath Ramsundar, Aneesh S. Pappu, Vijay Pande

Recent advances in machine learning have made significant contributions to drug discovery. Deep neural networks in particular have been demonstrated to provide significant boosts in predictive power when inferring the pr…

Drug DiscoveryMolecular Property PredictionOne-Shot Learning

A deep-learning view of chemical space designed to facilitate drug discovery

2020-02-07 · Paul Maragakis, Hunter Nisonoff, Brian Cole, David E. Shaw

Drug discovery projects entail cycles of design, synthesis, and testing that yield a series of chemically related small molecules whose properties, such as binding affinity to a given target protein, are progressively ta…

Design SynthesisDrug Discovery

Generating Focussed Molecule Libraries for Drug Discovery with Recurrent Neural Networks

2017-01-05 · Marwin H. S. Segler, Thierry Kogej, Christian Tyrchan, Mark P. Waller

In de novo drug design, computational strategies are used to generate novel molecules with good affinity to the desired biological target. In this work, we show that recurrent neural networks can be trained as generative…

Drug DesignDrug Discovery